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Aims: To evaluate the feasibility of the histopathological diagnosis of
prefibrotic–early primary myelofibrosis (PM) as described in the World Health
Organization (WHO) classification and to evaluate the clinical implications of
prefibrotic–early PM in a series of patients previously diagnosed as having
essential thrombocythemia (ET) according to the Polycythemia Vera Study Group
criteria.
Methods and results: WHO criteria were applied to bone marrow biopsy
specimens by two pathologists who then reclassified 127 cases as 102 ET (80.3%),
18 prefibrotic–early PM (14.2%) and seven fibrotic PM (5.5%). In 45 cases (35%),
the final diagnosis was only reached by consensus. The megakaryocytic criteria
that best discriminated between ET and prefibrotic–early PM were an increased
nucleo–cytoplasmic ratio, presence of cloudlike nuclei, hyperchromatic-dysplastic
nuclei, paratrabecular megakaryocytes and tight clusters. A histological score
discriminated between ET (score ≤3) and PM (score ≥6), but 21 cases showed an
intermediate ambiguous score. No significant differences were observed at
diagnosis and at follow-up (median time 93 months) for thrombosis, major
haemorrhage, laboratory data, transformation into overt myeloid metaplasia and
survival.
Conclusions: The distinction between ET and prefibrotic–early PM is impaired by
subjectivity in pathological practice and is of questionable clinical relevance, at
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